1 January 2012PatentsArchana Shanker

A step into the unknown: India's first compulsory license

The licence was granted to Natco Pharma, a generic drug company, for sorafenib tosylate, a life-extending drug developed, patented and launched by Bayer Corporation. This drug is sold under the trade name of Nexavar and is used for the treatment of advanced-stage kidney and liver cancer.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

India e-commerce: Liability for platforms is coming at last

24 September 2019 India’s booming e-commerce industry has remained largely immune to the cries of rights owners, but not for much longer, explains Pravin Anand, Jaya Negi and Souradeep Mukhopadhyay.

Influential Women in IP

The real impact of judgments

1 December 2020 Justice Prabha Sridevan has left her mark on the Indian IP industry, first as a judge of the Madras High Court, and then as chair of the Intellectual Property Appellate Board. Here, she tells WIPR about two cases that she will always remember.

Huawei wins seven-country ban on Netgear routers at the UPC

Lenovo faces US import ban as ITC sides with Ericsson

Arusha Protocol takes root: Fresh growth for plant variety protection in Africa

‘The politics of AI are developing’: Will Trump give tech a free ride?

‘AI curious’ counsel at AZ, Novartis and Orange weigh risks and benefits

China: Unpacking the first successful patent invalidation due to unauthorised foreign filing

SharkNinja overturns Dyson’s vacuum ban at the UPC

On our radar… Smashburger, OpenAI, Feminist Cyberlaw

A step into the unknown: India's first compulsory license

More on this story

Editor's picks

Editor's picks

More articles